These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of small ubiquitin-like modifier proteins-1 (SUMO-1) in regulating migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Lao M; Zhan Z; Li N; Xu S; Shi M; Zou Y; Huang M; Zeng S; Liang L; Xu H Exp Cell Res; 2019 Feb; 375(1):52-61. PubMed ID: 30562482 [TBL] [Abstract][Full Text] [Related]
5. The post-translational modification, SUMOylation, and cancer (Review). Han ZJ; Feng YH; Gu BH; Li YM; Chen H Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374 [TBL] [Abstract][Full Text] [Related]
6. Spatiotemporal distribution of small ubiquitin-like modifiers during human placental development and in response to oxidative and inflammatory stress. Baczyk D; Audette MC; Coyaud E; Raught B; Kingdom JC J Physiol; 2018 May; 596(9):1587-1600. PubMed ID: 29468681 [TBL] [Abstract][Full Text] [Related]
7. SUMO pathway components as possible cancer biomarkers. Mattoscio D; Chiocca S Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214 [TBL] [Abstract][Full Text] [Related]
8. SUMOylation in Skeletal Development, Homeostasis, and Disease. Liu H; Craig SEL; Molchanov V; Floramo JS; Zhao Y; Yang T Cells; 2022 Aug; 11(17):. PubMed ID: 36078118 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation. He X; Riceberg J; Pulukuri SM; Grossman S; Shinde V; Shah P; Brownell JE; Dick L; Newcomb J; Bence N PLoS One; 2015; 10(4):e0123882. PubMed ID: 25860128 [TBL] [Abstract][Full Text] [Related]
10. Basic fibroblast growth factor induces matrix metalloproteinase-13 via ERK MAP kinase-altered phosphorylation and sumoylation of Elk-1 in human adult articular chondrocytes. Im HJ; Sharrocks AD; Lin X; Yan D; Kim J; van Wijnen AJ; Hipskind RA Open Access Rheumatol; 2009; 1():151-161. PubMed ID: 27789988 [TBL] [Abstract][Full Text] [Related]
11. Potential Role of SUMO and SUMOylation in the Pathogenesis of Diabetes Mellitus. Sadeghi M; Dehnavi S; Shohan M; Jamialahmadi T; Sathyapalan T; Sahebkar A Curr Med Chem; 2023; 30(14):1623-1637. PubMed ID: 35980066 [TBL] [Abstract][Full Text] [Related]
12. The Roles of SUMO in Metabolic Regulation. Kamynina E; Stover PJ Adv Exp Med Biol; 2017; 963():143-168. PubMed ID: 28197911 [TBL] [Abstract][Full Text] [Related]
13. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy. Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449 [TBL] [Abstract][Full Text] [Related]
15. Sumoylation in Cellular Senescence and Aging. Gong L; Sun Q; Li DW Curr Mol Med; 2017; 16(10):871-876. PubMed ID: 28017139 [TBL] [Abstract][Full Text] [Related]
17. Emerging roles of the SUMO pathway in development. Lomelí H; Vázquez M Cell Mol Life Sci; 2011 Dec; 68(24):4045-64. PubMed ID: 21892772 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the sumoylation system in gene expression. Liu B; Shuai K Curr Opin Cell Biol; 2008 Jun; 20(3):288-93. PubMed ID: 18468876 [TBL] [Abstract][Full Text] [Related]
19. The role of SUMOylation in ageing and senescent decline. Princz A; Tavernarakis N Mech Ageing Dev; 2017 Mar; 162():85-90. PubMed ID: 28088449 [TBL] [Abstract][Full Text] [Related]